Galectin Therapeutics Announces Conversion of $105.8 Million in Debt to Equity, Significantly Strengthening Balance Sheet

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/18/2026

1. SPY
2. FLNC
3. CRM
4. GNRC
5. CRWV
6. NVDA
7. LEN
8. USO
9. LMT
10. TLT

Go back to Galectin Therapeutics Announces Conversion of $105.8 Million in Debt to Equity, Significantly Strengthening Balance Sheet
GALECTIN (NASDAQ: GALT) Delayed: 3.71 --0 (-0%)
Previous Close $3.71    52 Week High $3.05 
Open $3.71    52 Week Low $0.49 
Day High $3.71    P/E N/A 
Day Low $3.71    EPS $-1.32 
Volume 34